AIDS	acquired immune deficiency syndrome
AP-MS	affinity purification followed by mass spectrometry
ART	anti-retroviral therapy
BICD2	Bicaudal D2
CA	monomeric capsid protein
CFIm	cleavage factor I mammalian
CHD	CypA homologous domain
CPSF6	Cleavage and polyadenylation specificity factor subunit 6
CRISPR/Cas9	clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9
CypA	cyclophilin A
cyro-ET	cyro-electron tomography
DmrB	drug-inducible dimerization domain B
dNTPs	deoxynucleotide triphosphates
FDA	Food and Drug Administration
FEZ1	Fasciculation and Elongation Protein Zeta 1
HIV-1	The Human Immunodeficiency Virus type 1
IFNs	interferons
IN	integrase
IP6	inositol hexaphosphate
LC-MS/MS	liquid chromatography-tandem mass spectrometry
MHR	major homology region
MT	microtubule
MX2	myxovirus resistance 2
NPC	nuclear pore complex
Nup	nucleoporin
PDL	proximity-dependent labeling
PIC	pre-integration complex
PPIase	peptidyl-prolyl cis-trans isomerase
PPIs	protein–protein interactions
RING	Really Interesting New Gene
RNAi	RNA interference
RT	reverse transcriptase
SILAC	Stable Isotope Labeling with Amino acids in Cell culture
siRNA	small-interfering RNA
SPRY domain	SPla and the RYanodine Receptor
TAP	tandem affinity purification
TRIM5α	tripartite motif-containing protein 5 alpha
TRN-1	Transportin-1
Y2H	yeast two-hybrid